TTY Biopharm Company Limited (TPEX:4105)

TTY Biopharm Company Revenue

TTY Biopharm Company had revenue of 1.52B TWD in the quarter ending March 31, 2026, with 4.23% growth. This brings the company's revenue in the last twelve months to 6.51B, up 7.16% year-over-year. In the year 2025, TTY Biopharm Company had annual revenue of 6.45B with 9.49% growth.

• Revenue (ttm): 6.51B
• Revenue Growth: +7.16%
• P/S Ratio: 2.80
• Revenue / Employee: 19.05M
• Employees: 342
• Market Cap: 18.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.45B	559.10M	9.49%
Dec 31, 2024	5.89B	388.31M	7.05%
Dec 31, 2023	5.51B	443.94M	8.77%
Dec 31, 2022	5.06B	526.00M	11.60%
Dec 31, 2021	4.54B	313.77M	7.43%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error